Austria
· Delayed Price · Currency is EUR Novonesis Statistics
Total Valuation
Novonesis has a market cap or net worth of EUR 27.29 billion. The enterprise value is 28.74 billion.
| Market Cap | 27.29B |
| Enterprise Value | 28.74B |
Important Dates
The last earnings date was Thursday, May 8, 2025.
| Earnings Date | May 8, 2025 |
| Ex-Dividend Date | Apr 4, 2025 |
Share Statistics
| Current Share Class | 412.17M |
| Shares Outstanding | n/a |
| Shares Change (YoY) | -8.56% |
| Shares Change (QoQ) | +68.44% |
| Owned by Insiders (%) | n/a |
| Owned by Institutions (%) | n/a |
| Float | 346.64M |
Valuation Ratios
The trailing PE ratio is 59.52 and the forward PE ratio is 28.67.
| PE Ratio | 59.52 |
| Forward PE | 28.67 |
| PS Ratio | 6.73 |
| PB Ratio | 2.43 |
| P/TBV Ratio | 20.16 |
| P/FCF Ratio | 44.62 |
| P/OCF Ratio | 28.73 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 24.41, with an EV/FCF ratio of 46.99.
| EV / Earnings | 62.68 |
| EV / Sales | 7.08 |
| EV / EBITDA | 24.41 |
| EV / EBIT | 31.33 |
| EV / FCF | 46.99 |
Financial Position
The company has a current ratio of 1.66, with a Debt / Equity ratio of 0.15.
| Current Ratio | 1.66 |
| Quick Ratio | 1.03 |
| Debt / Equity | 0.15 |
| Debt / EBITDA | 1.44 |
| Debt / FCF | 2.78 |
| Interest Coverage | 11.41 |
Financial Efficiency
Return on equity (ROE) is 6.97% and return on invested capital (ROIC) is 7.25%.
| Return on Equity (ROE) | 6.97% |
| Return on Assets (ROA) | n/a |
| Return on Invested Capital (ROIC) | 7.25% |
| Return on Capital Employed (ROCE) | 6.64% |
| Revenue Per Employee | 383,444 |
| Profits Per Employee | 43,328 |
| Employee Count | 10,582 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +6.24% in the last 52 weeks.
| Beta (5Y) | n/a |
| 52-Week Price Change | +6.24% |
| 50-Day Moving Average | 55.24 |
| 200-Day Moving Average | 57.09 |
| Relative Strength Index (RSI) | 63.88 |
| Average Volume (20 Days) | 13 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Novonesis had revenue of EUR 4.06 billion and earned 458.50 million in profits. Earnings per share was 1.58.
| Revenue | 4.06B |
| Gross Profit | 2.14B |
| Operating Income | 921.70M |
| Pretax Income | 614.80M |
| Net Income | 458.50M |
| EBITDA | 1.18B |
| EBIT | 921.70M |
| Earnings Per Share (EPS) | 1.58 |
Balance Sheet
The company has 249.50 million in cash and 1.70 billion in debt, giving a net cash position of -1.45 billion.
| Cash & Cash Equivalents | 249.50M |
| Total Debt | 1.70B |
| Net Cash | -1.45B |
| Net Cash Per Share | n/a |
| Equity (Book Value) | 11.23B |
| Book Value Per Share | 24.09 |
| Working Capital | 775.70M |
Cash Flow
In the last 12 months, operating cash flow was 949.80 million and capital expenditures -338.20 million, giving a free cash flow of 611.60 million.
| Operating Cash Flow | 949.80M |
| Capital Expenditures | -338.20M |
| Free Cash Flow | 611.60M |
| FCF Per Share | n/a |
Margins
Gross margin is 52.73%, with operating and profit margins of 22.72% and 11.30%.
| Gross Margin | 52.73% |
| Operating Margin | 22.72% |
| Pretax Margin | 15.15% |
| Profit Margin | 11.30% |
| EBITDA Margin | 29.12% |
| EBIT Margin | 22.72% |
| FCF Margin | 15.07% |
Dividends & Yields
This stock pays an annual dividend of 0.83, which amounts to a dividend yield of 1.39%.
| Dividend Per Share | 0.83 |
| Dividend Yield | 1.39% |
| Dividend Growth (YoY) | -0.08% |
| Years of Dividend Growth | n/a |
| Payout Ratio | 54.46% |
| Buyback Yield | 8.56% |
| Shareholder Yield | 9.96% |
| Earnings Yield | 1.68% |
| FCF Yield | 2.24% |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
Novonesis has an Altman Z-Score of 5.71.
| Altman Z-Score | 5.71 |
| Piotroski F-Score | n/a |